Abstract
MacTel type 2 is the most common subtype that results in atrophic changes and sometimes subretinal neovascularization (SRN). This case report will focus on a patient with MacTel type 2 and the management and treatment options pertinent to the case.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
